What your physician is studying on Medscape.com:
MARCH 24, 2020 — Recommendations to assist clinicians triage surgical procedures throughout the COVID-19 pandemic, developed shortly by a staff of urology specialists from all over the world and shared final week, are already old-fashioned.
“I would change some things we said a week ago,” stated David Canes, MD, from Lahey Hospital and Medical Center in Burlington, Massachusetts and Derry, New Hampshire, who was a type of specialists.
“We now know it’s not possible to create a cookbook in the face of a rapidly evolving pandemic,” he informed Medscape Medical News.
“It’s heartening that we could do it so fast, but now it’s a snapshot in time, a starting point. People have to have conversations locally, in their community, taking into account where they are in relation to a surge of COVID patients, to make good decisions,” Canes stated.
Long-thought-out steering can not come from societies. “As the pace of information changes so rapidly,” Canes stated he has modified the best way he disseminates info and searches for steering. “I’m even looking to nontraditional channels, like Twitter.”
As the COVID-19 pandemic evolves, casual discussions on social media are serving to specialists make selections. “Threads about various cancers and how people are handling them are helpful,” he stated.
He described, for instance, a considerate dialogue on using androgen-deprivation remedy, a hormone remedy that may block the results of androgens and might sluggish the expansion of prostate most cancers. “This is not a standard-of-care treatment,” he stated, however now it is being mentioned very severely to deal with sufferers whose care may get delayed.
A multiple-choice survey was posted on Twitter by Ashish Kamat, MD, MBBS, from the MD Anderson Cancer Center in Houston, asking respondents what they might do for a affected person with stage T2 high-grade muscle invasive bladder most cancers and regular glomerular filtration throughout the pandemic.
In lower than 20 hours, his submit acquired 290 votes in response.
And when Badar Mian, MD, from the Albany Medical Center in New York, requested 23 urologists whether or not they would advocate radiotherapy (20 fractions) with none chemotherapy, he shortly received two responses: one sure and one no, with explanations.